About the Authors
- Aaron W. James
-
Contributed equally to this work with: Aaron W. James, Xinli Zhang, Mihaela Crisan
* E-mail: awjames@jhmi.edu
Affiliations Department of Pathology, Johns Hopkins University, Baltimore, Maryland, United States of America, UCLA and Orthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, Los Angeles, California, United States of America
- Xinli Zhang
-
Contributed equally to this work with: Aaron W. James, Xinli Zhang, Mihaela Crisan
Affiliation Division of Growth and Development and Section of Orthodontics, School of Dentistry, University of California Los Angeles, Los Angeles, California, United States of America
- Mihaela Crisan
-
Contributed equally to this work with: Aaron W. James, Xinli Zhang, Mihaela Crisan
Affiliation Center for Cardiovascular Science and MRC Center for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
- Winters R. Hardy
-
Affiliation UCLA and Orthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, Los Angeles, California, United States of America
- Pei Liang
-
Affiliation UCLA and Orthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, Los Angeles, California, United States of America
- Carolyn A. Meyers
-
Affiliation Department of Pathology, Johns Hopkins University, Baltimore, Maryland, United States of America
- Sonja Lobo
-
Affiliation UCLA and Orthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, Los Angeles, California, United States of America
- Venu Lagishetty
-
Affiliation UCLA and Orthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, Los Angeles, California, United States of America
- Martin K. Childers
-
Affiliation Rehabilitation Medicine Clinic, UWMC, Seattle, Washington, United States of America
- Greg Asatrian
-
Affiliation Division of Growth and Development and Section of Orthodontics, School of Dentistry, University of California Los Angeles, Los Angeles, California, United States of America
- Catherine Ding
-
Affiliation Division of Growth and Development and Section of Orthodontics, School of Dentistry, University of California Los Angeles, Los Angeles, California, United States of America
- Yu-Hsin Yen
-
Affiliation Department of Pathology, Johns Hopkins University, Baltimore, Maryland, United States of America
- Erin Zou
-
Affiliation Department of Pathology, Johns Hopkins University, Baltimore, Maryland, United States of America
- Kang Ting
-
Affiliation Division of Growth and Development and Section of Orthodontics, School of Dentistry, University of California Los Angeles, Los Angeles, California, United States of America
- Bruno Peault
-
¶‡ These authors also contributed equally to this work as co-senior authors.
Affiliations UCLA and Orthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, Los Angeles, California, United States of America, Center for Cardiovascular Science and MRC Center for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
- Chia Soo
-
¶‡ These authors also contributed equally to this work as co-senior authors.
Affiliations UCLA and Orthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, Los Angeles, California, United States of America, Division of Plastic and Reconstructive Surgery, Department of Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
Competing Interests
KT and CS are inventors of perivascular stem cell-related patents filed from UCLA. KT and CS are founders of Scarless Laboratories, Inc. which sublicenses perivascular stem cell-related patents from the UC Regents, and who also hold equity in the company. CS is also an officer of Scarless Laboratories, Inc. XZ, KT and CS are inventors of NELL-1-related patents. XZ, KT and CS are founders and/or board members of Bone Biologics Inc., which sublicenses NELL-1 patents from the UC Regents, and also hold equity in the company. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The relevant patent titles and patent/patent publication numbers are listed below: “Compositions comprising perivascular stem cells and nell-1 protein”: Patent number: US-9,301,976; Patent publication numbers; US 20130309207, WO 2012024573 A2, EP 2606121; B1, “Perivascular stem cell composition for bone” Patent publication numbers: US 2012/0244128 A1, WO2011022070 A2; “Nell-1 enhanced bone mineralization”: Patent number: US-8,207,120, US-7,776,361, US-7,052,856, and US-7884,066; Patent publication number: US20090060988 A1, WO 2001024821 A1. US8207120 B2, EP1551978 A2”; “NELL-1 peptide(s)”: Patent number: US-8,053,412 and US-7,807,787; Patent publication numbers: US8053412 B2, US7807787 B2; “Nell-1 compositions” Patent publication number: CA2704190 A1; “Nell peptide expression systems and bone formation activity of nell peptide” Patent number WO2004072100A2; “Isoform nell-1 peptide” US patent number: US-9,447,155; Patent publication number WO2010111421 A3.
Author Contributions
Conceptualization: AWJ WRH XZ BP. Data curation: XZ MC PL BP VL SL MKC. Formal analysis: AWJ XZ MC CAM PL VL SL MKC. Funding acquisition: AWJ KT BP CS. Investigation: MC PL CAM. Methodology: AWJ WRH XZ. Project administration: XZ. Resources: AWJ WRH XZ KT BP CS. Supervision: AWJ XZ. Visualization: CAM YHY EZ GA CD. Writing – original draft: CAM. Writing – review & editing: CAM AWJ.